Navigation Links
Moderate Growth in $26 Billion Respiratory Devices: Report
Date:4/3/2017

ROCKVILLE, Md., April 3, 2017 /PRNewswire/ -- Kalorama Information says that the world market for respiratory devices will experience moderate growth due to an increasing aging population and increasing respiratory diseases worldwide. Even though there is ongoing pressure to cut costs in 2017 and beyond, respiratory device growth outlook remains positive in the respiratory market, according to the market research publisher.   The market encompasses many different products to help treat and monitor respiratory conditions as well as many large and small manufacturers. Respiratory devices have grown impressively in many of the categories over last few years. Continued demand for respiratory medical equipment will likely be fueled by rising incidence of respiratory diseases such as sleep apnea, asthma, and COPD.  The bulk of the growth of the market is expected to arise from an increasing incidence of COPD worldwide and innovative products entering the market.

The size of the respiratory device market is 25.6 billion according to Kalorama's most recent report: The World Market for Respiratory Devices.

Products included in the worldwide respiratory device market are:

  • Inhalers 
  • Nebulizers
  • Airway/Mask equipment
  • Sleep apnea equipment
  • Oxygen therapy equipment and ventilators
  • Medical humidifiers
  • Respiratory measurement  and diagnostic devices

The market also will grow thanks to the shifting trend towards the use of home care products for the graying population across the globe.  The demand for respiratory devices in the United States will continue to escalate due to an aging population and prevalence of respiratory disease but will be tempered somewhat by reimbursement and cost cutting measures. In Europe, the outlook is cautious due to new European product directives but there is a drive to modernize healthcare systems in Europe. Market growth in Asia Pacific is likely to be highest in China due to higher standard of living, better healthcare and government investment in healthcare.  Brazil is expected to contribute moderate to high growth over the forecast period due to investments in healthcare infrastructure and rising awareness of respiratory diseases and treatments.   Advancements in respiratory devices along with a strong desire to maintain good health will positively influence the outlook for the world market for respiratory devices.  Kalorama's report contains figures for COPD devices and sleep apnea markets. 

Companies in respiratory devices include: 3M, Philips/Respironics, ResMed, Inc., Teleflex and Becton Dickinson, among others.  The worldwide respiratory device industry has been highly fragmented in nature. The majority of the companies in this industry excel in a few segments, such as inhalers or respiratory measurement and diagnostic devices, humidification or oxygen therapy devices. This fragmentation leads to plethora of competitors that are both regional and local in nature. Many companies have a narrow segment focus.

The World Market for Respiratory Devices (Inhalers, Nebulizers, Airways, Masks, Sleep Apnea, Oxygen Therapy, Ventilators Medical Humidifiers, Respiratory Measurement) provides revenue data for the global and geographic opportunities for respiratory equipment.  The report can be found at: http://www.kaloramainformation.com/Respiratory-Devices-Inhalers-10725525/.

For more Kalorama reports on medical devices visit: https://www.kaloramainformation.com/medical-devices-market-c1126/.

About Kalorama Information

Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. Reports can be purchased through Kalorama's website and are also available on www.marketresearch.com and www.profound.com.

We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog on our company website.  

Please link any media or news references to our reports or data to http://www.kaloramainformation.com/.

Press Contact:                                                        
Bruce Carlson
212 807 2262                                                         
bcarlson@marketresearch.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/moderate-growth-in-26-billion-respiratory-devices-report-300429229.html


'/>"/>
SOURCE Kalorama Information
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Rheumatoid Arthritis Patients are Moderately to Highly Satisfied with Their Current Drug Therapy, Rating Conventional DMARDs Highest on Ease of Use and Cost
2. Five-Year SIMPONI Data Reported In Treatment Of Signs And Symptoms Of Moderately To Severely Active Rheumatoid Arthritis
3. Takeda Submits Biologics License Application for a New Investigational Drug Vedolizumab, in Moderately to Severely Active Crohns Disease and Ulcerative Colitis in the United States
4. New data about the safety and efficacy of linagliptin in adults with type 2 diabetes who have moderate to severe renal impairment presented at ADA
5. For Moderate to Severe Psoriasis, Thought Leaders Opinions and Clinical Data Indicate That Emerging Biologics That Target IL-17 Have the Potential to Offer Improvements in Efficacy and Safety Over Current Therapies
6. An Expanding Patient Pool And Technological Innovation Will Drive Moderate Growth In The US Market For Biopsy Devices
7. Final Patient Completes Prosonix Phase 2 Clinical Study with PSX1002 in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
8. Data Published in the New England Journal of Medicine for Vedolizumab, an Investigational New Drug from Takeda for Moderately to Severely Active Ulcerative Colitis and Crohns Disease
9. Olodaterol Shows Sustained Improvements in Lung Function in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
10. Data for Investigational Tiotropium Show Improved Lung Function and Sustained Bronchodilation in Patients with Moderate Asthma Severity
11. Greater Efficacy on Cognition and Function Over Current Treatments Remain Neurologists Top Unmet Need in Mild to Moderate Alzheimers Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2017)... May 17, 2017  Bayer announced today that the ... be presented at the 53 rd Annual Meeting ... place June 2-6 in Chicago . ... span prostate, colorectal, liver and thyroid cancers, as well ... Phase II CHRONOS-1 trial of copanlisib in patients with ...
(Date:5/15/2017)... 2017 Enterin Inc., a privately-held CNS pharmaceutical company ... compounds to treat Parkinson,s disease (PD), has enrolled the first ... 1/2a randomized, controlled, multicenter study involving patients with PD and ... patients over a 9-to-12-month period. The first stage is open ... PD. Participating sites include Denver , ...
(Date:5/11/2017)...  Thornhill Research Inc. ( Toronto, Ontario, ... USD five-year, firm-fixed-priced, indefinite-quantity/indefinite-delivery contract by the U.S. ... (CCC) ( Ottawa, Ontario, Canada ) ... anesthesia to patients requiring emergency medical procedures in ... Corps have been a longtime partner with Thornhill ...
Breaking Medicine Technology:
(Date:5/26/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh ... the Peace Agreements being discussed by President Donald Trump and the rest of the ... to speed up peace talks in the continuous battle between Israel and Palestine. The ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... “When the ... Lead Home” is the creation of published author Laura Weigel Douglas, an avid reader ... cat in a house that sometimes feels like Green Hills Adventure Camp. She couldn’t ...
(Date:5/26/2017)... ... May 26, 2017 , ... “Cactus Jack: Against All Odds”: ... many others. “Cactus Jack: Against All Odds” is the creation of published author, ... Hubbard is married to Jack Carlisle’s third child Jane. Walter. Walter and Jane ...
(Date:5/24/2017)... (PRWEB) , ... May 24, 2017 , ... Dr. Alan ... surgery in New York City. He is known for his distinguished expertise and ... vascular surgery, Dr. Benvenisty holds sub-specialty training in treating renovascular disease and aortic ...
(Date:5/24/2017)... ... ... Dr. Manju R. Kejriwal, a leading Ohio dentist, is now welcoming new ... Dr. Kejriwal understands the emotional and financial toll traditional orthodontics can take on patients’ ... longer need to feel the esthetic effects of wires and brackets when they can ...
Breaking Medicine News(10 mins):